|
necrosis as a novel approach to eliminate tumor cells. BMC Cancer,
|
20 |
14, 14: 74. DOI: 10.1186/1471-2407-14-74.
|
[3] |
Voigt S, Philipp S, Davarnia P, et al. TRAIL-induced programmed
|
[1] |
Bakalian S, Marshall JC, Logan P, et al. Molecular pathways
|
[4] |
Huang W, Huang M, Ouyang H, et al. Oridonin inhibits vascular
|
|
necrosis as a novel approach to eliminate tumor cells. BMC Cancer,
|
20 |
14, 14: 74. DOI: 10.1186/1471-2407-14-74.
|
|
mediating liver metastasis in patients with uveal melanoma. Clin
|
|
Cancer Res, 2008, 14(4): 951-956. DOI: 10.1158/1078-0432.
|
|
inflammation by blocking NF-κB and MAPK activation. Eur J
|
|
Pharmacol, 2018, 826: 133-139. DOI: 10.1016/j.ejphar.2018.02.044.
|
|
CCR-06-2630.
|
[4] |
Huang W, Huang M, Ouyang H, et al. Oridonin inhibits vascular
|
[5] |
Dong X, Liu F, Li M. Inhibition of nuclear factor κB transcription
|
[2] |
Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of
|
|
inflammation by blocking NF-κB and MAPK activation. Eur J
|
|
Pharmacol, 2018, 826: 133-139. DOI: 10.1016/j.ejphar.2018.02.044.
|
|
life and death. J Clin Immunol, 2003, 23(5): 317-332.
|
|
activity drives a synergistic effect of cisplatin and oridonin on
|
[5] |
Dong X, Liu F, Li M. Inhibition of nuclear factor κB transcription
|
[3] |
Voigt S, Philipp S, Davarnia P, et al. TRAIL-induced programmed
|
|
HepG2 human hepatocellular carcinoma cells. Anticancer Drugs,
|
20 |
16, 27(4): 286-299. DOI: 10.1097/CAD.0000000000000329.
|
|
activity drives a synergistic effect of cisplatin and oridonin on
|
|
necrosis as a novel approach to eliminate tumor cells. BMC Cancer,
|
20 |
14, 14: 74. DOI: 10.1186/1471-2407-14-74.
|
[6] |
Liu JB, Yue JY. Preliminary study on the mechanism of
|
|
HepG2 human hepatocellular carcinoma cells. Anticancer Drugs,
|
20 |
16, 27(4): 286-299. DOI: 10.1097/CAD.0000000000000329.
|
[4] |
Huang W, Huang M, Ouyang H, et al. Oridonin inhibits vascular
|
|
oridonin-induced apoptosis in human squamous cell oesophageal
|
[6] |
Liu JB, Yue JY. Preliminary study on the mechanism of
|
|
carcinoma cell line EC9706. J Int Med Res, 2014, 42(4): 984-
|
99 |
2. DOI: 10.1177/0300060513507389.
|
|
inflammation by blocking NF-κB and MAPK activation. Eur J
|
|
Pharmacol, 2018, 826: 133-139. DOI: 10.1016/j.ejphar.2018.02.044.
|
|
oridonin-induced apoptosis in human squamous cell oesophageal
|
[7] |
Ye YC, Wang HJ, Xu L, et al. Oridonin induces apoptosis and
|
[5] |
Dong X, Liu F, Li M. Inhibition of nuclear factor κB transcription
|
|
carcinoma cell line EC9706. J Int Med Res, 2014, 42(4): 984-
|
99 |
2. DOI: 10.1177/0300060513507389.
|
|
autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53
|
|
activity drives a synergistic effect of cisplatin and oridonin on
|
[7] |
Ye YC, Wang HJ, Xu L, et al. Oridonin induces apoptosis and
|
|
positive-feedback loop signaling pathway. Acta Pharmacol Sin, 2012,
|
33 |
(8): 1055-1061. DOI: 10.1038/aps.2012.53.
|
|
HepG2 human hepatocellular carcinoma cells. Anticancer Drugs,
|
20 |
16, 27(4): 286-299. DOI: 10.1097/CAD.0000000000000329.
|
|
autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53
|
[6] |
Liu JB, Yue JY. Preliminary study on the mechanism of
|
[8] |
Paschall AV, Yang D, Lu C, et al. H3K9 trimethylation silences
|
|
positive-feedback loop signaling pathway. Acta Pharmacol Sin, 2012,
|
33 |
(8): 1055-1061. DOI: 10.1038/aps.2012.53.
|
|
oridonin-induced apoptosis in human squamous cell oesophageal
|
|
fas expression to confer colon carcinoma immune escape and
|
[8] |
Paschall AV, Yang D, Lu C, et al. H3K9 trimethylation silences
|
|
carcinoma cell line EC9706. J Int Med Res, 2014, 42(4): 984-
|
99 |
2. DOI: 10.1177/0300060513507389.
|
5- |
fluorouracil chemoresistance. J Immunol, 2015, 195(4): 1868-
|
18 |
82. DOI: 10.4049/jimmunol.1402243.
|
|
fas expression to confer colon carcinoma immune escape and
|
[7] |
Ye YC, Wang HJ, Xu L, et al. Oridonin induces apoptosis and
|
[9] |
Wu J, Ding Y, Chen CH, et al. A new oridonin analog suppresses
|
5- |
fluorouracil chemoresistance. J Immunol, 2015, 195(4): 1868-
|
18 |
82. DOI: 10.4049/jimmunol.1402243.
|
|
autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53
|
|
triple-negative breast cancer cells and tumor growth via the
|
[9] |
Wu J, Ding Y, Chen CH, et al. A new oridonin analog suppresses
|
|
positive-feedback loop signaling pathway. Acta Pharmacol Sin, 2012,
|
33 |
(8): 1055-1061. DOI: 10.1038/aps.2012.53.
|
|
induction of death receptor 5. Cancer Lett, 2016, 380(2): 393-
|
40 |
2. DOI: 10.1016/j.canlet.2016.06.024.
|
|
triple-negative breast cancer cells and tumor growth via the
|
[8] |
Paschall AV, Yang D, Lu C, et al. H3K9 trimethylation silences
|
[10] |
Yang IH, Shin JA, Lee KE, et al. Oridonin induces apoptosis in
|
|
induction of death receptor 5. Cancer Lett, 2016, 380(2): 393-
|
40 |
2. DOI: 10.1016/j.canlet.2016.06.024.
|
|
human oral cancer cells via phosphorylation of histone H2AX.
|
|
Eur J Oral Sci, 2017, 125(6): 438-443. DOI: 10.1111/eos.12387.
|
|
fas expression to confer colon carcinoma immune escape and
|
[10] |
Yang IH, Shin JA, Lee KE, et al. Oridonin induces apoptosis in
|
[11] |
Xiao X, He Z, Cao W, et al. Oridonin inhibits gefitinib-resistant
|
|
human oral cancer cells via phosphorylation of histone H2AX.
|
|
Eur J Oral Sci, 2017, 125(6): 438-443. DOI: 10.1111/eos.12387.
|
5- |
fluorouracil chemoresistance. J Immunol, 2015, 195(4): 1868-
|
18 |
82. DOI: 10.4049/jimmunol.1402243.
|
[11] |
Xiao X, He Z, Cao W, et al. Oridonin inhibits gefitinib-resistant
|
|
lung cancer cells by suppressing EGFR/ERK/MMP-12 and
|
[9] |
Wu J, Ding Y, Chen CH, et al. A new oridonin analog suppresses
|
|
lung cancer cells by suppressing EGFR/ERK/MMP-12 and
|
|
CIP2A/Akt signaling pathways. Int J Oncol, 2016, 48(6): 2608-
|
26 |
18. DOI: 10.3892/ijo.2016.3488.
|
|
triple-negative breast cancer cells and tumor growth via the
|
|
CIP2A/Akt signaling pathways. Int J Oncol, 2016, 48(6): 2608-
|
26 |
18. DOI: 10.3892/ijo.2016.3488.
|
[12] |
Zhu M, Hong D, Bao Y, et al. Oridonin induces the apoptosis of
|
|
induction of death receptor 5. Cancer Lett, 2016, 380(2): 393-
|
40 |
2. DOI: 10.1016/j.canlet.2016.06.024.
|
|
metastatic hepatocellular carcinoma cells via a mitochondrial pathway.
|
|
Oncol Lett, 2013, 6(5): 1502-1506. DOI: 10.3892/ol.2013.1541.
|
[12] |
Zhu M, Hong D, Bao Y, et al. Oridonin induces the apoptosis of
|
[10] |
Yang IH, Shin JA, Lee KE, et al. Oridonin induces apoptosis in
|
|
metastatic hepatocellular carcinoma cells via a mitochondrial pathway.
|
|
Oncol Lett, 2013, 6(5): 1502-1506. DOI: 10.3892/ol.2013.1541.
|
[13] |
Gui Z, Li S, Liu X, et al. Oridonin alters the expression profiles
|
|
human oral cancer cells via phosphorylation of histone H2AX.
|
|
Eur J Oral Sci, 2017, 125(6): 438-443. DOI: 10.1111/eos.12387.
|
[13] |
Gui Z, Li S, Liu X, et al. Oridonin alters the expression profiles
|
|
of microRNAs in BxPC-3 human pancreatic cancer cells. BMC
|
|
Complement Altern Med, 2015, 15: 117. DOI: 10.1186/s12906-
|
[11] |
Xiao X, He Z, Cao W, et al. Oridonin inhibits gefitinib-resistant
|
01 |
5-0640-5.
|
|
of microRNAs in BxPC-3 human pancreatic cancer cells. BMC
|
|
Complement Altern Med, 2015, 15: 117. DOI: 10.1186/s12906-
|
|
lung cancer cells by suppressing EGFR/ERK/MMP-12 and
|
01 |
5-0640-5.
|
[14] |
Wang H, Zhu L, Feng X, et al. Oridonin induces G2/M cell cycle
|
|
CIP2A/Akt signaling pathways. Int J Oncol, 2016, 48(6): 2608-
|
26 |
18. DOI: 10.3892/ijo.2016.3488.
|
|
arrest and apoptosis in human oral squamous cell carcinoma. Eur J
|
|
Pharmacol, 2017, 815: 282-289. DOI: 10.1016/j.ejphar.2017.09.021.
|
[14] |
Wang H, Zhu L, Feng X, et al. Oridonin induces G2/M cell cycle
|
[12] |
Zhu M, Hong D, Bao Y, et al. Oridonin induces the apoptosis of
|
[15] |
Gasparian ME, Bychkov ML, Yagolovich AV, et al. The effect
|
|
arrest and apoptosis in human oral squamous cell carcinoma. Eur J
|
|
Pharmacol, 2017, 815: 282-289. DOI: 10.1016/j.ejphar.2017.09.021.
|
|
metastatic hepatocellular carcinoma cells via a mitochondrial pathway.
|
|
Oncol Lett, 2013, 6(5): 1502-1506. DOI: 10.3892/ol.2013.1541.
|
[15] |
Gasparian ME, Bychkov ML, Yagolovich AV, et al. The effect
|
|
of cisplatin on cytotoxicity of anticancer cytokine TRAIL and its
|
[13] |
Gui Z, Li S, Liu X, et al. Oridonin alters the expression profiles
|
|
of cisplatin on cytotoxicity of anticancer cytokine TRAIL and its
|
|
receptor-selective mutant variant DR5-B1. Dokl Biochem Biophys,
|
20 |
17, 477(1): 385-388. DOI: 10.1134/S1607672917060114.
|
|
of microRNAs in BxPC-3 human pancreatic cancer cells. BMC
|
|
Complement Altern Med, 2015, 15: 117. DOI: 10.1186/s12906-
|
01 |
5-0640-5.
|
|
receptor-selective mutant variant DR5-B1. Dokl Biochem Biophys,
|
20 |
17, 477(1): 385-388. DOI: 10.1134/S1607672917060114.
|
[16] |
Zhang W, Zhou J, Zhu X, et al. MiR-126 reverses drug resistance to
|
|
TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
|
|
Gene, 2017, 627: 420-427. DOI: 10.1016/j.gene.2017.06.055.
|
[17] |
潘敏, 刘莉, 张丽武. 紫杉醇联合顺铂新辅助化疗及放疗在早中
|
|
期宫颈癌治疗中的临床应用. 当代医学, 2018, 24(3): 116-117.
|
[18] |
李小安, 房殿春, 司佩任, 等. TRAIL与5-Fu合用对结肠癌细胞
|
|
系SW480杀伤作用的研究. 第三军医大学学报, 2003, 25(18):
|
16 |
40-1642. DOI: 10.3321/j.issn.1000-5404.2003.18.015.
|
[19] |
马芹, 陈伟, 陈文. 去氢骆驼蓬碱衍生物B-9-3与5种传统抗肿
|
|
瘤药联用的体外抑瘤作用. 药物评价研究, 2018, 41(1): 61-66.
|
[14] |
Wang H, Zhu L, Feng X, et al. Oridonin induces G2/M cell cycle
|
[16] |
Zhang W, Zhou J, Zhu X, et al. MiR-126 reverses drug resistance to
|
|
TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
|
|
Gene, 2017, 627: 420-427. DOI: 10.1016/j.gene.2017.06.055.
|
[17] |
潘敏, 刘莉, 张丽武. 紫杉醇联合顺铂新辅助化疗及放疗在早中
|
|
期宫颈癌治疗中的临床应用. 当代医学, 2018, 24(3): 116-117.
|
[18] |
李小安, 房殿春, 司佩任, 等. TRAIL与5-Fu合用对结肠癌细胞
|
|
系SW480杀伤作用的研究. 第三军医大学学报, 2003, 25(18):
|
16 |
40-1642. DOI: 10.3321/j.issn.1000-5404.2003.18.015.
|
[19] |
马芹, 陈伟, 陈文. 去氢骆驼蓬碱衍生物B-9-3与5种传统抗肿
|
|
瘤药联用的体外抑瘤作用. 药物评价研究, 2018, 41(1): 61-66.
|
[20] |
Peter L, Natalie R, Katsuyukl T, et a1. Suppression of apoptosis
|
|
arrest and apoptosis in human oral squamous cell carcinoma. Eur J
|
|
Pharmacol, 2017, 815: 282-289. DOI: 10.1016/j.ejphar.2017.09.021.
|
|
in mammalian cells by NAPI and a related family of IAP genes.
|
[20] |
Peter L, Natalie R, Katsuyukl T, et a1. Suppression of apoptosis
|
[15] |
Gasparian ME, Bychkov ML, Yagolovich AV, et al. The effect
|
|
Nature, 1996, 379(15): 349-353.
|
|
in mammalian cells by NAPI and a related family of IAP genes.
|
|
Nature, 1996, 379(15): 349-353.
|
|
of cisplatin on cytotoxicity of anticancer cytokine TRAIL and its
|
[21] |
Carter BZ, Milella M, Tsao T, et al. Regulation and targeting of
|
|
receptor-selective mutant variant DR5-B1. Dokl Biochem Biophys,
|
20 |
17, 477(1): 385-388. DOI: 10.1134/S1607672917060114.
|
[21] |
Carter BZ, Milella M, Tsao T, et al. Regulation and targeting of
|
|
antiapoptotic XIAP in acute myeloid leukemia. Leukemia, 2003,
|
17 |
(11): 2081-2089. DOI: 10.1038/sj.leu.2403113.
|
[16] |
Zhang W, Zhou J, Zhu X, et al. MiR-126 reverses drug resistance to
|
|
antiapoptotic XIAP in acute myeloid leukemia. Leukemia, 2003,
|
17 |
(11): 2081-2089. DOI: 10.1038/sj.leu.2403113.
|
|
TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
|
|
Gene, 2017, 627: 420-427. DOI: 10.1016/j.gene.2017.06.055.
|
[17] |
潘敏, 刘莉, 张丽武. 紫杉醇联合顺铂新辅助化疗及放疗在早中
|
|
期宫颈癌治疗中的临床应用. 当代医学, 2018, 24(3): 116-117.
|
[18] |
李小安, 房殿春, 司佩任, 等. TRAIL与5-Fu合用对结肠癌细胞
|
|
系SW480杀伤作用的研究. 第三军医大学学报, 2003, 25(18):
|
16 |
40-1642. DOI: 10.3321/j.issn.1000-5404.2003.18.015.
|
[19] |
马芹, 陈伟, 陈文. 去氢骆驼蓬碱衍生物B-9-3与5种传统抗肿
|
|
瘤药联用的体外抑瘤作用. 药物评价研究, 2018, 41(1): 61-66.
|
[20] |
Peter L, Natalie R, Katsuyukl T, et a1. Suppression of apoptosis
|
|
in mammalian cells by NAPI and a related family of IAP genes.
|
|
Nature, 1996, 379(15): 349-353.
|
[21] |
Carter BZ, Milella M, Tsao T, et al. Regulation and targeting of
|
|
antiapoptotic XIAP in acute myeloid leukemia. Leukemia, 2003,
|
17 |
(11): 2081-2089. DOI: 10.1038/sj.leu.2403113.
|